Report Adverse Event or Product Quality Complaint   US Site   Global Site             

Header Logo
  • Prescribing Information
  • Therapy areas
    • All Therapeutic Areas
    • Cardiovascular, Renal and Metabolism
    • Immunology
    • Infection
    • Oncology
    • Rare Disease (Alexion)
    • Respiratory
  • Disease Education
  • Resources
    • Congress Library
    • Clinical Trials
    • Continuing Education
    • Patient Support
    • Pipeline
  • Connect
    • Connect with an MSL
    • Connect with an MSL
    • Submit an MIR
    • Give Feedback

Search Medical Information

Login

Request a field medical follow-up

  • Home
  • Prescribing Information

Prescribing Information

  1. All (44)
  2. Cardiovascular, Renal and Metabolism (17)
  3. Immunology (1)
  4. Infection (1)
  5. Oncology (9)
  6. Rare Disease (6)
  7. Respiratory (9)

AIRSUPRA®

(albuterol and budesonide) inhalation aerosol

Prescribing Information

ANDEXXA®

(coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection

Prescribing Information

BEVESPI AEROSPHERE®

(glycopyrrolate and formoterol fumarate) inhalation aerosol

Prescribing Information

BREZTRI AEROSPHERE®

(budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol

Prescribing Information

BRILINTA®

(ticagrelor) Tablets

Prescribing Information

BYDUREON BCise®

(exenatide extended-release) injectable suspension

Prescribing Information

BYETTA®

(exenatide) Injection

Prescribing Information

CALQUENCE®

(acalabrutinib) Tablets

Prescribing Information

CRESTOR®

(rosuvastatin calcium) Tablets

Prescribing Information

DALIRESP®

(roflumilast) Tablets

Prescribing Information

DATROWAY®

(datopotamab deruxtecan-dlnk)

Prescribing Information

ENHERTU®

(fam-trastuzumab deruxtecan-nxki)

Prescribing Information

FARXIGA®

(dapagliflozin) Tablets

Prescribing Information

FASENRA®

(benralizumab) injection, for subcutaneous use

Prescribing Information

FASLODEX®

(fulvestrant) injection, for intramuscular use

Prescribing Information

FLUMIST®

(Influenza Vaccine Live, Intranasal)

Prescribing Information

IMFINZI®

(durvalumab) injection, for intravenous use

Prescribing Information

IMJUDO®

(tremelimumab)

Prescribing Information

IRESSA®

(gefitinib) Tablets

Prescribing Information

KANUMA®

(sebelipase alfa) injection, for intravenous use

Prescribing Information

KOMBIGLYZE® XR

(saxagliptin and metformin HCl extended-release) Tablets

Prescribing Information

KOSELUGO®

(selumetinib) capsules, for oral use

Prescribing Information

LOKELMA®

(sodium zirconium cyclosilicate) for Oral Suspension

Prescribing Information

LOKELMA®

(sodium zirconium cyclosilicate) for Oral Suspension Spanish

Prescribing Information

LYNPARZA®

(olaparib) Tablets

Prescribing Information

NEXIUM®

(esomeprazole magnesium) for delayed-release oral suspension and delayed-release capsules

Prescribing Information

ONGLYZA®

(saxagliptin) Tablets

Prescribing Information

PULMICORT RESPULES®

(budesonide inhalation suspension)

Prescribing Information

QTERN®

(dapagliflozin and saxagliptin) Tablets

Prescribing Information

SAPHNELO™

(anifrolumab-fnia) Injection

Prescribing Information

SEROQUEL XR®

(quetiapine) Extended-Release Tablets

Prescribing Information

SEROQUEL®

(quetiapine fumarate) Tablets

Prescribing Information

SOLIRIS®

(eculizumab) injection, for intravenous use

Prescribing Information

STRENSIQ®

(asfotase alfa) injection, for subcutaneous use

Prescribing Information

SYMBICORT®

(budesonide/formoterol fumarate dihydrate) Inhalation Aerosol

Prescribing Information

SYMBICORT®

Spanish

Prescribing Information

SYMLIN®

(pramlintide acetate) Injection

Prescribing Information

TAGRISSO®

(osimertinib) Tablets

Prescribing Information

TEZSPIRE®

(tezepelumab-ekko) Injection, for subcutaneous use

Prescribing Information

TRUQAP®

(capivasertib)

Prescribing Information

ULTOMIRIS®

(ravulizumab-cwvz) injection, for intravenous use

Prescribing Information

VOYDEYA™

(danicopan) tablets, for oral use

Prescribing Information

WAINUA™

(eplontersen)

Prescribing Information

XIGDUO® XR

(dapagliflozin and metformin HCI extended-release) Tablets

Prescribing Information

ANDEXXA®

(coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection

Prescribing Information

BRILINTA®

(ticagrelor) Tablets

Prescribing Information

BYDUREON BCise®

(exenatide extended-release) injectable suspension

Prescribing Information

BYETTA®

(exenatide) Injection

Prescribing Information

CRESTOR®

(rosuvastatin calcium) Tablets

Prescribing Information

FARXIGA®

(dapagliflozin) Tablets

Prescribing Information

KOMBIGLYZE® XR

(saxagliptin and metformin HCl extended-release) Tablets

Prescribing Information

LOKELMA®

(sodium zirconium cyclosilicate) for Oral Suspension

Prescribing Information

LOKELMA®

(sodium zirconium cyclosilicate) for Oral Suspension Spanish

Prescribing Information

NEXIUM®

(esomeprazole magnesium) for delayed-release oral suspension and delayed-release capsules

Prescribing Information

ONGLYZA®

(saxagliptin) Tablets

Prescribing Information

QTERN®

(dapagliflozin and saxagliptin) Tablets

Prescribing Information

SEROQUEL XR®

(quetiapine) Extended-Release Tablets

Prescribing Information

SEROQUEL®

(quetiapine fumarate) Tablets

Prescribing Information

SYMLIN®

(pramlintide acetate) Injection

Prescribing Information

WAINUA™

(eplontersen)

Prescribing Information

XIGDUO® XR

(dapagliflozin and metformin HCI extended-release) Tablets

Prescribing Information

SAPHNELO™

(anifrolumab-fnia) Injection

Prescribing Information

FLUMIST®

(Influenza Vaccine Live, Intranasal)

Prescribing Information

CALQUENCE®

(acalabrutinib) Tablets

Prescribing Information

ENHERTU®

(fam-trastuzumab deruxtecan-nxki)

Prescribing Information

FASLODEX®

(fulvestrant) injection, for intramuscular use

Prescribing Information

IMFINZI®

(durvalumab) injection, for intravenous use

Prescribing Information

IMJUDO®

(tremelimumab)

Prescribing Information

IRESSA®

(gefitinib) Tablets

Prescribing Information

LYNPARZA®

(olaparib) Tablets

Prescribing Information

TAGRISSO®

(osimertinib) Tablets

Prescribing Information

TRUQAP®

(capivasertib)

Prescribing Information

KANUMA®

(sebelipase alfa) injection, for intravenous use

Prescribing Information

KOSELUGO®

(selumetinib) capsules, for oral use

Prescribing Information

SOLIRIS®

(eculizumab) injection, for intravenous use

Prescribing Information

STRENSIQ®

(asfotase alfa) injection, for subcutaneous use

Prescribing Information

ULTOMIRIS®

(ravulizumab-cwvz) injection, for intravenous use

Prescribing Information

VOYDEYA™

(danicopan) tablets, for oral use

Prescribing Information

AIRSUPRA®

(albuterol and budesonide) inhalation aerosol

Prescribing Information

BEVESPI AEROSPHERE®

(glycopyrrolate and formoterol fumarate) inhalation aerosol

Prescribing Information

BREZTRI AEROSPHERE®

(budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol

Prescribing Information

DALIRESP®

(roflumilast) Tablets

Prescribing Information

FASENRA®

(benralizumab) injection, for subcutaneous use

Prescribing Information

PULMICORT RESPULES®

(budesonide inhalation suspension)

Prescribing Information

SYMBICORT®

(budesonide/formoterol fumarate dihydrate) Inhalation Aerosol

Prescribing Information

SYMBICORT®

Spanish

Prescribing Information

TEZSPIRE®

(tezepelumab-ekko) Injection, for subcutaneous use

Prescribing Information
Connessiallasalute.it

This site is intended for healthcare professionals practicing in the US.
©2026 AstraZeneca. All rights reserved.

US-107328
Last Updated 3/26

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities  

Survey Feedback

Your Privacy Choice

Consumer Health Data 
Privacy Notice

Privacy Notice | Legal Notice | Cookie Preferences

Welcome to AstraZeneca Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

 

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

 

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?
This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States